-
1
Pretreatment 18F‐FDG uptake heterogeneity may predict treatment outcome of combined Trastuzumab and Pertuzumab therapy in patients with metastatic HER2 positive breast cancer
Published 2023-09-01Subjects: “…Heterogeneity of 18F-FDG uptake…”
Get full text
Article